International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
Duffield AS, Mullighan CG, Borowitz MJ.
Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24.
Update on Lymphoblastic Leukemia/Lymphoma.
Luca DC.
Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003.
B Cell Lymphoma.
Meng X, Min Q, Wang JY.
Adv Exp Med Biol. 2020;1254:161-181. doi: 10.1007/978-981-15-3532-1_12.
T-cell acute lymphoblastic leukemia.
Raetz EA, Teachey DT.
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):580-588. doi: 10.1182/asheducation-2016.1.580.
B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapy.
Zhang X, Rastogi P, Shah B, Zhang L.
Oncotarget. 2017 Jul 15;8(39):66728-66741. doi: 10.18632/oncotarget.19271. eCollection 2017 Sep 12.
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K, Sheikh T, Aggarwal N.
Semin Diagn Pathol. 2023 May;40(3):202-215. doi: 10.1053/j.semdp.2023.04.003. Epub 2023 Apr 9.
Lenalidomide-Associated Secondary B-Lymphoblastic Leukemia/Lymphoma-A Unique Entity.
Germans SK, Kulak O, Koduru P, Oliver D, Gagan J, Patel P, Anderson LD Jr, Fuda FS, Chen W, Jaso JM.
Am J Clin Pathol. 2020 Nov 4;154(6):816-827. doi: 10.1093/ajcp/aqaa109.
Acute myelofibrosis superseding B-lymphoblastic leukemia/lymphoma.
El Hussein S, O'Dywer KM, Bennett JM.
EJHaem. 2023 Aug 8;4(4):1179-1181. doi: 10.1002/jha2.769. eCollection 2023 Nov.
Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults.
Temple WC, Mueller S, Hermiston ML, Burkhardt B.
Best Pract Res Clin Haematol. 2023 Mar;36(1):101449. doi: 10.1016/j.beha.2023.101449. Epub 2023 Feb 16.
BCR-ABL1-like B-lymphoblastic leukemia/lymphoma: Review of the entity and detection methodologies.
Conant JL, Czuchlewski DR.
Int J Lab Hematol. 2019 May;41 Suppl 1:126-130. doi: 10.1111/ijlh.13012.
